Drawing for Serial No. 87716243

USPTO serial 87716243

Serial No. 87716243

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MAYES, LAURIE ANN
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with Serial No. 87716243?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Karen A. Webb, Paul Famiglietti

PAUL FAMIGLIETTI FENWICK & WEST LLPSILICON VALLEY CENTER801 CALIFORNIA STREETMOUNTAIN VIEW, CA 94041

Goods and services

ClassDescriptionStatusFirst use
009Software for recruiting patients for medical and scientific research and clinical trials and studies; Software for management of medical and scientific research and clinical trials and studies; Software for the design and administration of clinical, medical, and biological research studiesABANDONED—
035Recruitment of patients for medical and scientific research and clinical trials and studies; Recruitment advertisement services, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials; Business consultation services for clinical trials and research studies of others, namely, assisting in recruiting patients for participation in clinical trials for the testing of drugs; Advertising, promotion, and marketing services in the nature of using social and digital media technology to recruit new patients for medical providers and to match patients to clinical studies; Business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approvalABANDONED—
042Conducting clinical trials for others; Conducting clinical trials for others in the field of pharmaceutical products; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research and development; Providing temporary use of on-line non-downloadable software for management of medical and scientific research and clinical trials and studies; Providing temporary use of a web-based software application for tracking medical patients, patient records, patient biometrics, patient surgeries and outcomes of medical procedures for patients; Software as a service (SAAS) services featuring software to recruit patients for medical and scientific research and clinical trials and studies; Software as a service (SAAS) services featuring software for enabling users to view, manage and report on patient-reported data in pharmaceutical industry clinical trials; Providing a website featuring information in the field of clinical researchABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 7, 2019MAB4ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION—
Mar 7, 2019ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Mar 7, 2019OP.TOPPOSITION TERMINATED NO. 999999—
Mar 7, 2019OP.DOPPOSITION DISMISSED NO. 999999—
Aug 29, 2018OP.IOPPOSITION INSTITUTED NO. 999999—
May 24, 2018ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 1, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 1, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 11, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 23, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 23, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Mar 23, 2018ALIEASSIGNED TO LIE—
Mar 23, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Mar 23, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Mar 23, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Mar 21, 2018DOCKASSIGNED TO EXAMINER—
Dec 22, 2017MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Dec 21, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 14, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance